Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk
Daniele Campa; Katja Butterbach; Susan L. Slager; Christine F. Skibola; Silvia De Sanjosé; Yolanda Benavente; Nikolaus Becker; Lenka Foretova; Marc Maynadie; Pierluigi Cocco; et al. (Profiled Authors: Sara S Strom; Rudolf Kaaks)
International Journal of Cancer. 2012;131(4):803-812.
AbstractOwing to their role in controlling the efflux of toxic compounds, transporters are central players in the process of detoxification and elimination of xenobiotics, which in turn is related to cancer risk. Among these transporters, ATP-binding cassette B1/multidrug resistance 1 (ABCB1/MDR1), ABCC2/multidrug resistance protein 2 (MRP2) and ABCG2/breast cancer resistance protein (BCRP) affect susceptibility to many hematopoietic malignancies. The maintenance of regulated expression of these transporters is governed through the activation of intracellular "xenosensors" like the nuclear receptor 1I2/pregnane X receptor (NR1I2/PXR). SNPs in genes encoding these regulators have also been implicated in the risk of several cancers. Using a tagging approach, we tested the hypothesis that common polymorphisms in the transporter genes ABCB1, ABCC2, ABCG2 and the regulator gene NR1I2 could be implicated in lymphoma risk. We selected 68 SNPs in the four genes, and we genotyped them in 1,481 lymphoma cases and 1,491 controls of the European case-control study (EpiLymph) using the Illumina GoldenGate® assay technology. Carriers of the SNP rs6857600 minor allele in ABCG2 was associated with a decrease in risk of B-cell lymphoma (B-NHL) overall (p < 0.001). Furthermore, a decreased risk of chronic lymphocytic leukemia (CLL) was associated with the ABCG2 rs2231142 variant (p = 0.0004), which could be replicated in an independent population. These results suggest a role for this gene in B-NHL susceptibility, especially for CLL. Copyright © 2011 UICC.
PMID: 21918980
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2010Sean M Post; Vinod Pant; Hussein Abbas; Alfonso Quintás-Cardama
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
Oncotarget. 2010;1(3):168-174. -
2.
2008Helene F. S. Negaard; Per Ole Iversen; Bjørn Østenstad; Nina Iversen; Pål A. Holme; Per Morten Sandset
Thrombosis and Haemostasis. 2008;99(6):1040-1048. -
3.
2011Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Tiziana Vaisitti; Claudio Tripodo; Francesco Forconi; Lorenzo De Paoli; Marco Fangazio; Elisa Sozzi; Emanuele Cencini; et al.
British Journal of Haematology. 2011;152(3):284-294.
Related Topics
Appears in this Document
Related Experts
Author of this Document
-
Internal ExpertsPublications
-
624









-
170









-
192









-
1111









-
98









-
60









